Skip to content

In his quest to cure his daughter’s ultra-rare disease, Matt Wilsey might also be changing the way drugs are made, Stanford Business magazine reports.

In his quest to cure his daughter’s ultra-rare disease, Matt Wilsey might also be changing the way drugs are made, Stanford Business magazine reports.

Published on

Carolyn Bertozzi, the co-director of Stanford's interdisciplinary program ChEM-H, reflects here on the program and her goals for the future.

Carolyn Bertozzi, the co-director of Stanford's interdisciplinary program ChEM-H, reflects here on the program and her goals for the future.

Published on

I knew that many of the drugs we use today were first identified in plants. What I didn’t know was in how many cases those …

Published on